recombinant factor VIII

Recombinant factor VIII is a lab-made protein used to treat people with hemophilia A, a condition where the blood doesn’t clot properly due to a deficiency of this factor. Instead of relying on donations from blood donors, scientists produce recombinant factor VIII using genetically engineered cells, ensuring a pure, safe supply. When injected into a patient, it helps restore the blood’s ability to clot, preventing or stopping bleeding episodes. This technology has improved the safety and availability of treatment for hemophilia patients worldwide.